Cellugyrin, a Novel Ubiquitous Form of Synaptogyrin That Is Phosphorylated by pp60c-src*

Roger Janz and Thomas C. SüdhofDagger

From the Department of Molecular Genetics and Howard Hughes Medical Institute, The University of Texas Southwestern Medical Center, Dallas, Texas 75235

    ABSTRACT
Top
Abstract
Introduction
Procedures
Results
Discussion
References

Synaptogyrin is an abundant membrane protein of synaptic vesicles containing four transmembrane regions and a C-terminal cytoplasmic tail that is tyrosine phosphorylated. We have now identified a novel isoform of synaptogyrin called cellugyrin that exhibits 47% sequence identity with synaptogyrin. In rat tissues, cellugyrin and synaptogyrins are expressed in mirror image patterns. Cellugyrin is ubiquitously present in all tissues tested with the lowest levels in brain tissue, whereas synaptogyrin protein is only detectable in brain. Transfection studies in COS cells demonstrated that both cellugyrin and synaptogyrin are tyrosine phosphorylated in vivo by pp60c-src, and experiments with recombinant proteins showed that pp60c-src phosphorylates the cytoplasmic tails of these proteins in vitro. Cellugyrin and synaptogyrin co-localize when transfected into COS cells but are differentially distributed in brain, the only tissue where both proteins are detectable. Our data suggest that the synaptic vesicle protein synaptogyrin is a specialized version of a ubiquitous protein, cellugyrin, with the two proteins sharing structural similarity but differing in localization. This finding supports the emerging concept of synaptic vesicles as the simplified and specialized form of a generic trafficking organelle. The conserved tyrosine phosphorylation of cellugyrin and synaptogyrins suggests a link between tyrosine phosphorylation via pp60c-src and membrane traffic.

    INTRODUCTION
Top
Abstract
Introduction
Procedures
Results
Discussion
References

Synaptic vesicles represent specialized secretory organelles that store neurotransmitters in nerve terminals. Their function is to release neurotransmitters by fusing with the presynaptic plasma membrane during exocytosis. Synaptic vesicle exocytosis is a highly regulated Ca2+-dependent process. After exocytosis, empty synaptic vesicles are recycled and reloaded with neurotransmitters. It has been shown that the protein composition of synaptic vesicles is rather simple with a limited number of major proteins (reviewed in Ref. 1). Functions for some vesicle proteins have been identified, for example essential roles for synaptotagmin and synaptobrevin in Ca2+-triggered exocytosis (2-4). Others, such as rab3A (5-7) and synapsins (8, 9), play a modulatory role. However, for several vesicle proteins no function has yet been elucidated including synaptogyrin and synaptophysin. Synaptogyrin and synaptophysins I and II (synaptoporin) are among the most abundant vesicle proteins. Synaptophysin I alone accounts for 7% of the total vesicle membrane protein (10). Synaptogyrin and synaptophysins contain four transmembrane regions with cytoplasmic N and C termini, are distantly related to each other, and are tyrosine phosphorylated on synaptic vesicles by an endogenous kinase (11-14). The tyrosine kinase pp60c-src is peripherally associated with synaptic vesicles and phosphorylates synaptophysin I in vitro (15-17). The role of this modification is not clear but it could participate in the regulation of synaptic exocytosis.

Originally synaptic vesicles were thought to be very different from other exocytotic organelles, especially exocytotic vesicles that are involved in constitutive exocytosis. This hypothesis was based on the exquisite specificity of the localization of synaptic vesicle proteins to synapses and on the unusual degree of regulation of synaptic vesicle exocytosis. However, results in recent years revealed that many vesicle proteins have closely related homologues in constitutive ubiquitous vesicular trafficking pathways. The first such protein characterized was cellubrevin, which contains a central sequence that is almost identical to that of synaptobrevin and can also be cleaved by tetanus toxin, suggesting a conserved mechanism of membrane fusion in regulated and constitutive exocytotic pathways (18). Since then, isoforms of synaptophysin, rab3, and synaptotagmins have been found outside of neurons, indicating a general parallelism between Ca2+-triggered membrane traffic at the synapse and Ca2+-independent membrane traffic in all cells (19-21). For other abundant vesicle proteins like synaptogyrin, however, no corresponding homologue outside of the nervous system has been characterized, raising the question of whether there are, after all, proteins that are specific for synaptic vesicles.

We describe here the characterization of a protein, cellugyrin, that is closely related to synaptogyrin but widely expressed in non-neuronal tissues. Cellugyrin, like synaptogyrin, is tyrosine phosphorylated, suggesting a link between membrane traffic and tyrosine phosphorylation that is conserved between regulated and constitutive membrane-trafficking pathways. Our data support the notion that synaptic vesicle traffic is closely related to ubiquitous membrane-trafficking pathways with similar protein components not only in fusion but also in regulation.

    EXPERIMENTAL PROCEDURES
Top
Abstract
Introduction
Procedures
Results
Discussion
References

cDNA Cloning and Construction of Expression Vectors-- Homology searches identified a single class of synaptogyrin homologues in the human and mouse EST data banks. A restriction fragment (approx 1-kb1 HindIII/PstI fragment) from a human EST clone (IMAGE 51526 from Research Genetics Inc.) was used to screen rat brain and liver lambda ZAP cDNA libraries (12). Analysis of nine distinct positive clones showed that they contained overlapping sequences of the same mRNA (cellugyrin). A full-length sequence was assembled and inserted as a 1.09-kb fragment into the EcoRI-XbaI sites of pCMV5 (22), creating the expression vector pCMV-Cgyr similar to the synaptogyrin expression vector (pCMV-Sgyr) (12). The expression vector for the neuronal splice form of mouse pp60c-src was generated by cloning a 1.8-kb BamHI fragment from clone pN1.8 (23) into the BglII site of pCMV5. The bacterial expression vector pMAL-CGyr encoding the residues 180 to 234 of cellugyrin (Fig. 1) fused to maltose-binding protein was constructed by polymerase chain reaction in pMAL-c2 (New England Biolabs) using the EcoRI and HindIII sites. The corresponding GST-fusion protein vector pGEX-CGyr was constructed similarly in pGEX-KG. Recombinant proteins were produced in Escherichia coli BL21 cells by standard procedures.

Cell Culture and Immunofluorescence Microscopy-- COS cells were cultured in Dulbecco's modified Eagle's medium with 10% fetal bovine serum and transfected using DEAE-dextran with chloroquin and a 2-min glycerol shock as described by Gorman (24) with 6.6 µg DNA for 900,000 cells in a 10-cm dish. For biochemical analyses, cells were washed with phosphate-buffered saline 72 h after transfections, harvested in SDS-polyacrylamide gel electrophoresis sample buffer, passed 10 times through a 25-gauge needle to shear the DNA, and stored at -70 °C. For immunofluorescence studies, cells were split 24 h after transfection, plated on polylysine-coated glass coverslips, and fixed 48 h later in 4% paraformaldehyde, 0.1 M phosphate buffer, and 0.25 M sucrose for 20 min. Cells were then permeabilized with 0.3% Triton X-100 in phosphate-buffered saline for 10 min, blocked overnight with 2% goat serum in phosphate-buffered saline at 4 °C, and reacted with primary and secondary antibodies in 2% goat serum. As specificity controls, the signal was blocked with recombinant GST-cellugyrin fusion protein, or COS cells transfected with control DNA were used.

Western Blots-- Immunoblot analyses of tissue extracts or transfected COS cells were performed as described with ECL detection (11). Blots to be probed with anti-phosphotyrosine antibodies were preblocked for 1 h in TBST with 1% bovine serum albumin, 10% goat serum, and 1 mM vanadate. Blots for all other antibodies were preblocked with TBST containing 5% goat serum and 5% nonfat milk powder. For the specific blocking experiments, 5 mg/liter GST-cellugyrin (containing the same cellugyrin sequence as the maltose-binding protein fusion protein) or GST were added as recombinant proteins to the blots together with the antiserum.

Antibodies-- An antiserum was raised against maltose-binding protein-cellugyrin (encoded by pMAL-CGyr) in rabbits and used at a dilution of 1:1,000. The synaptogyrin antibody was described before (12, 14) and used in dilutions of 1:5,000-1:10,000. The anti-phosphotyrosine antibody RC20 was obtained coupled to peroxidase (from Transduction Laboratories) and used in a dilution of 1:2,500. The monoclonal pp60c-src antibody was a gift from Dr. B. Barylko. Peroxidase-coupled and fluorescently labeled secondary antibodies were from Cappel and Jackson ImmunoResearch, respectively.

Northern Blots-- A 906-bp fragment of the cellugyrin cDNA containing 649 bp of coding region and 257 bp 3'-untranslated region, and a 582-bp EcoRI/BamHI fragment from pCMV-SGyr containing 24 bp 5'-untranslated and 558 bp coding region were labeled with [alpha -32P]dCTP and used as probes on a multitissue Northern blot from CLONTECH according to the manufacturer's protocol.

Subcellular Fractionations-- For total rat tissue homogenates, tissues were homogenized in 10 volumes of phosphate-buffered saline with 5 mM EDTA and 0.1 mM phenylmethylsulfonyl fluoride on ice. After protein determinations (Bio-Rad), the homogenate was adjusted to 5 g/liter protein, mixed with 2 × SDS-polyacrylamide gel electrophoresis sample buffer, and stored at -70 °C until use. For organelle separations, fresh rat liver or brain was homogenized in 10 volumes of 0.25 M sucrose, 50 mM Hepes-NaOH, pH 7.4, 0.1 mM EDTA with protease inhibitors (phenylmethylsulfonyl fluoride, leupeptin, pepstatin, aprotinin). The homogenate was centrifuged for 10 min at 600 × g (nuclear pellet = P1). The supernatant was spun again at 10,000 × g for 15 min (mitochondrial pellet = P2). A third centrifugation of the supernatant at 100,000 × g for 30 min produced pellet P3 (microsomes) and the supernatant S3. All fractions were adjusted to the same protein concentration by dilution and mixed with sample buffer, and 20 µg protein each were analyzed by SDS-polyacrylamide gel electrophoresis and immunoblotting. Synaptic vesicles, purified by controlled pore glass chromatography as described by Jahn et al.(10), were a kind gift of R. Jahn (Yale University) and S. Butz (University of Texas Southwestern Medical School).

    RESULTS
Top
Abstract
Introduction
Procedures
Results
Discussion
References

Primary Structure of Cellugyrin-- To identify genes that are homologous to synaptogyrin, we used the sequence of rat brain synaptogyrin to search EST data banks for other isoforms. Only two classes of human EST sequences with significant homology to rat brain synaptogyrin were found; one class of ESTs with a high degree of homology to rat synaptogyrin (>80%) that presumably corresponds to the human ortholog of rat synaptogyrin (not shown); a second class contained a lower degree of homology to synaptogyrin (37-55% identity) that was distributed across the entire protein sequence, suggesting that the second class corresponds to a novel isoform of synaptogyrin. Since the EST data banks are thought to be nearly saturated, our results suggest that there are only two major forms of synaptogyrin in humans, the previously characterized neuronal form (12) and a novel isoform.

We employed a human EST clone corresponding to the novel isoform (IMAGE 51526) to screen a rat brain and liver cDNA library and isolated one positive clone from brain and eight from liver. The sequences of the clones were assembled into a full-length sequence with an open reading frame of 234 amino acids (Fig. 1). Because this protein is highly homologous to synaptogyrin but ubiquitously expressed in all cells tested (see below), we named the protein cellugyrin.


View larger version (91K):
[in this window]
[in a new window]
 
Fig. 1.   Structures of cellugyrin and related proteins. Alignment of the sequences of cellugyrin, synaptogyrin, synaptophysins I and II (synaptoporin), and pantophysin is shown. The four transmembrane regions of the proteins are numbered and marked by thick black lines above the sequences. Putative intramolecular disulfide bonds formed by cysteines in the intravesicular loops are indicated by thin lines above and below the sequences (see text). Residues that are identical between the majority of sequences are shown on a red background, residues identical between cellu- and synaptogyrins are shown on a green background, and residues identical between synaptophysins I and II, and pantophysin are shown on a blue background. Tyrosine residues that are conserved in the cytoplasmic sequences of cellu- and synaptogyrins are marked by asterisks. Sequences are numbered on the right.

Structures of Cellu-/Synaptogyrins and Synaptophysins Define Distantly Related Protein Families-- Data bank searches with the cellugyrin sequence confirmed that it is closely related to synaptogyrin (47% identity between rat synapto- and cellugyrins) and weakly homologous to synaptophysins. The overall identity between cellu-/synaptogyrins and synaptophysins is low (identities with cellugyrin: synaptophysin I = 14.5%; synaptophysin II/synaptoporin = 12%; pantophysin = 10%). Their relation becomes only apparent if one considers the overall similarity in structure and the higher homology between segments of their sequences that are related to each other in a statistically significant manner (Fig. 1). The synaptophysins are more closely related to each other than they are to cellu-/synaptogyrins, but less closely than cellugyrin is related to synaptogyrin. Together these data define two families of highly homologous proteins that are distantly related to each other.

Analysis of the cellu-/synaptogyrin and synaptophysin sequences reveals interesting similarities and differences. All of these proteins have four transmembrane regions. The transmembrane topologies of synaptophysin I and synaptogyrin were mapped biochemically, demonstrating that both N and C termini are cytoplasmic (11, 12). The sequence similarity between cellu- and synaptogyrin suggests that they have similar transmembrane topologies. The two intravesicular loops of synaptophysins and cellu-/synaptogyrins are highly conserved within each of the two protein families but exhibit no similarity between the families. The largest domains of the synaptophysins and cellu-/synaptogyrins are their cytoplasmic C-terminal tails; here cellu- and synaptogyrins are closely related to each other but again exhibit no homology to synaptophysins. In addition, the three different synaptophysins exhibit only distant similarities to each other in their C-terminal tails (Fig. 1). The lack of homology in the intravesicular loops and cytoplasmic tails between cellu-/synaptogyrins and synaptophysins contrasts with the transmembrane regions. These are the most homologous parts of these proteins (Fig. 1). Thus the cellu-/synaptogyrins and synaptophysins are composed of an array of transmembrane regions that are highly conserved but are flanked by nonconserved intravesicular loops and cytoplasmic tails.

The intravesicular loops of the synaptophysins are longer than those in cellu-/synaptogyrins and contain two conserved cysteines each that form an intramolecular disulfide bond within each loop (25). The first but not the second intravesicular loop of the cellu-/synaptogyrins also has a pair of cysteine residues that could potentially form intramolecular disulfide bonds similar to synaptophysins or intermolecular disulfide bonds. To test this, we analyzed the subunit structure of cellu- and synaptogyrins on nonreducing gels (data not shown). Synaptogyrin or cellugyrin did not shift to higher apparent molecular weights in the absence of reducing agents, suggesting that they are not disulfide linked to each other or to another protein. The similarity of cellu-/synaptogyrins to synaptophysins suggests that an intramolecular disulfide bond may be formed by the two cysteines in the first intravesicular loop.

RNA Blot Analysis of Cellugyrin Expression-- To determine which tissues express cellugyrin, we hybridized a multitissue RNA blot with a cellugyrin probe at high stringency (Fig. 2). A single mRNA of approximately 1.7 kb was detected with abundant expression in all tissues except for low levels in testis and brain. When we reprobed the same blot for synaptogyrin, we found that the highest levels of the 4.2-kb synaptogyrin mRNA were present in brain with lower but detectable levels in several other tissues, in particular kidney (Fig. 2). In addition to the bona fide 4.2-kb synaptogyrin mRNA, the synaptogyrin probe detected in several non-brain tissues two small mRNAs that do not produce a synaptogyrin protein (see below) and whose significance is unclear. Together these data demonstrate that the cellu- and synaptogyrin mRNAs are expressed in a mirror-image pattern. Cellugyrin mRNA is ubiquitously present in all tissues tested with lowest levels in brain whereas synaptogyrin mRNA is synthesized at high levels only in brain.


View larger version (31K):
[in this window]
[in a new window]
 
Fig. 2.   RNA blot analysis of the expression of cellu- and synaptogyrins in rat tissues. The same multitissue RNA blot (obtained from CLONTECH) was consecutively hybridized with a cellugyrin probe (top panel) and a synaptogyrin probe (bottom panel). The origin of the 1.5- and 1.0-kb bands observed with the synaptogyrin probe in nonbrain tissues is unclear since the sizes of the RNAs are too small for synaptogyrin mRNAs and no synaptogyrin protein is detectable in these tissues (see Fig. 3).

Expression of Cellugyrin Protein-- To test if the protein encoded by the cellugyrin mRNA is actually synthesized, we raised an antibody to the C-terminal 57 residues of cellugyrin fused to maltose-binding protein. Immunoblots with this antibody of extracts from COS cells transfected with a cellugyrin expression vector revealed a band of the appropriate size (29 kDa) that was absent in control COS cells (Fig. 3, left two lanes in the left panels). The signal in the transfected COS cells could be blocked with a GST-fusion protein containing the C terminus of cellugyrin but not with GST alone (Fig. 3). The cellugyrin antibody did not react with synaptogyrin, and synaptogyrin antibodies did not react with cellugyrin (Fig. 3, left two lanes in the right panels). Therefore there is no immunological cross-reactivity between cellu- and synaptogyrins.


View larger version (54K):
[in this window]
[in a new window]
 
Fig. 3.   Immunoblot analysis of the tissue distribution of expression of cellu- and synaptogyrins in rat. Proteins from COS cells transfected with expression vectors encoding cellugyrin (pCMV-Cgyr) or synaptogyrin (pCMV-Sgyr) and from the indicated rat tissues (25 µg/lane) were analyzed with antibodies to cellugyrin (left panels) or synaptogyrin (right panels). Immunoblots were probed with the antibodies in the presence of GST as a nonspecific blocking agent (top panels) or GST-cellugyrin as a specific blocking agent (bottom panels). Note that protein bands nonspecifically labeled by the cellugyrin antibody do not become abolished with the specific block GST-cellugyrin (arrowheads); only the specific signal is abolished. The GST-cellugyrin block, however, has no effect on the synaptogyrin signal (right panels). Numbers on the left indicate positions of molecular weight markers.

Next we investigated if rat tissues contain cellugyrin protein. Immunoblots revealed that the cellugyrin antibody reacted with a major 29-kDa protein that co-migrates with transfected cellugyrin and is present in most tissues but barely detectable in brain (Fig. 3). In addition, reactivity with several additional proteins of larger apparent molecular weight was observed. When we blocked the antibody with the GST-cellugyrin fusion protein, only the signal for the 29-kDa protein but not the signal for the other proteins was abolished, suggesting that the other immunoreactivities are nonspecific (Fig. 3, left panels, arrowheads). Addition of GST alone had no effect. Thus the 29-kDa band corresponds to cellugyrin, which is widely expressed as protein in most rat tissues except for brain. Similar blots were also probed for synaptogyrin, revealing that synaptogyrin protein was only detectable in brain but not in other tissues, not even kidney which contains significant mRNA levels (compare Fig. 3, right panels with Fig. 2). Therefore the mirror-image pattern of tissue-specific expression observed for the cellu- and synaptogyrin mRNAs blots is also found with the corresponding proteins.

Subcellular Localization of Synaptogyrin and Cellugyrin-- The sequence similarity between cellugyrin and synaptogyrin suggests related functions, whereas their differential distributions indicate that they perform these functions for different cells. To gain first insights into the subcellular localization of cellu- and synaptogyrin, we overexpressed them by transfection in COS cells and studied their localization by immunofluorescence microscopy (Fig. 4 and data not shown). In transfected COS cells, both proteins produced very similar staining patterns, suggesting that they are localized to the same compartment. This was confirmed by double-labeling experiments of COS cells co-transfected with both proteins (Fig. 4). Although the exact localization of a protein is difficult to evaluate in overexpression studies, most of the protein stain was present in a reticular or microvesicular pattern, suggesting that the two proteins are sorted into the same compartments, which resemble those previously characterized for cells transfected with synaptophysin (26).


View larger version (47K):
[in this window]
[in a new window]
 
Fig. 4.   Co-localization of cellugyrin and synaptogyrin in transfected COS cells. COS cells were co-transfected with cellugyrin and synaptogyrin and reacted with the rabbit cellugyrin antibody (panel A) and a monoclonal synaptogyrin antibody (panel B) followed by CY3coupled anti-rabbit and fluorescein isothiocyanate-coupled anti-mouse secondary antibodies. Panel C depicts a superposition of panels A and B.

We next evaluated the localization of endogenous cellugyrin in tissues. Since the cellugyrin antibodies cross-react with abundant unknown proteins in most tissues (Fig. 3), it was not possible to perform immunocytochemistry. Therefore we used subcellular fractionation of rat liver and brain as a first measure of localizing these proteins. Our data show that in liver, cellugyrin is highly enriched in microsomes, a fraction that contains small vesicles, endoplasmic reticulum, and plasma membrane, but is basically absent from nuclei or mitochondria. A similar distribution was observed in brain, the only tissue in which both cellu- and synaptogyrin are detectable. Comparison of the distribution of cellu- and synaptogyrin in brain showed that they co-enrich in microsomes (Fig. 5, lane 4). However, they are localized to distinct organelles in brain. Synaptogyrin, as described previously, is highly enriched in synaptic vesicles (Fig. 5, panel C, lane 6). Cellugyrin in contrast is completely absent from synaptic vesicles (Fig. 5, panel B, lane 6), possibly because it is not expressed by neurons but by glia cells. Thus synapto- and cellugyrin are both primarily found in light membranes but in brain, cellugyrin is not present on synaptic vesicles.


View larger version (50K):
[in this window]
[in a new window]
 
Fig. 5.   Subcellular distribution of cellugyrin analyzed by tissue fractionation. Rat liver and brain homogenates (lane 1, total) were subfractionated using differential centrifugation into crude nuclear fractions (lane 2, P1; 600 × g pellet), crude mitochondrial fractions (lane 3, P2; 10,000 × g pellet), microsomes (lane 4, P3; 100,000 × g pellet) and cytosol (lane 5, S3; 100,000 × g supernatant). Synaptic vesicles purified by controlled pore glass chromatography from a microsomal fraction of synaptosomes (lane 6) and COS cells transfected with cellugyrin expression vector (lane 7, pCMV-Cgyr) or synaptogyrin expression vector (lane 8, pCMV-Sgyr) were also obtained. Samples were analyzed by immunoblotting for cellugyrin and synaptogyrin as indicated. Nonspecifically reacting proteins in the cellugyrin blots are labeled with arrowheads (see also Fig. 3).

Synaptogyrin and Cellugyrin Are Tyrosine Phosphorylated by pp60c-src-- Previous studies showed that in synaptic vesicles, synaptogyrin and synaptophysin are tyrosine phosphorylated, and pp60c-src is associated with synaptic vesicles (14-16). This prompted us to ask if cellu- and synaptogyrin could represent a conserved family of tyrosine-phosphorylated trafficking proteins. To address this question, we co-transfected COS cells with expression vectors encoding the neuronal splice variant of pp60c-src and synapto- or cellugyrin. The COS cells were then analyzed by immunoblotting with antibodies against the transfected proteins and against phosphotyrosine to test if cellu- and synaptogyrin were tyrosine phosphorylated in a pp60c-src-dependent manner. In addition, the localization of cellu- and synaptogyrin was studied as a function of pp60c-src expression.

Transfection of pp60c-src alone resulted in the appearance of a single major tyrosine-phosphorylated protein that was identified by immunoblotting as pp60c-src (Fig. 6). However, when we co-transfected synaptogyrin with pp60c-src, we observed a second tyrosine-phosphorylated protein of 29 kDa. Immunoblotting confirmed that this protein corresponded to synaptogyrin (Fig. 6). When we transfected synaptogyrin without pp60c-src, no tyrosine phosphorylation was observed. These data confirm that synaptogyrin is a tyrosine-phosphorylated protein, and demonstrate that it is a substrate for pp60c-src in vivo. To test if cellugyrin is also a substrate, we performed analogous transfection experiments with pp60c-src and cellugyrin expression vectors with virtually identical results (Fig. 7). In fact, based on signal strength, cellugyrin was a better substrate for pp60c-src than synaptogyrin. However, immunocytochemistry revealed that in the transfected COS cells, the distribution of cellu- and synaptogyrin did not change as a function of tyrosine phosphorylation (data not shown).


View larger version (28K):
[in this window]
[in a new window]
 
Fig. 6.   Tyrosine phosphorylation of synaptogyrin by pp60c-src in COS cells. COS cells were co-transfected in the indicated combinations with a control vector (pCMV5), a vector encoding synaptogyrin (pCMV-Sgyr), a vector encoding neuronal pp60c-src (pCMV-N-Csrc), or salmon sperm DNA (SS DNA). Proteins from transfected COS cells were analyzed by immunoblotting with antibodies to phosphotyrosine (Anti-P-Tyr; top), synaptogyrin (middle), and pp60c-src (bottom). Positions of molecular weight standards are indicated on the right. Arrows point to the migration of pp60c-src (approx 60 kDa) and synaptogyrin (approx 30 kDa). Note that tyrosine-phosphorylated synaptogyrin is only present if pp60c-src is co-transfected with synaptogyrin.


View larger version (26K):
[in this window]
[in a new window]
 
Fig. 7.   Tyrosine phosphorylation of cellugyrin by pp60c-src in COS cells. COS cells were co-transfected in the indicated combinations with a control vector (pCMV5), a vector encoding cellugyrin (pCMV-Cgyr), a vector encoding neuronal pp60c-src (pCMV-N-Csrc), or salmon sperm DNA (SS DNA), and analyzed as discussed in the legend to Fig. 4. Note that similar to the situation for synaptogyrin, tyrosine-phosphorylated cellugyrin is only present if pp60c-src is co-transfected with cellugyrin.

Together these data show that cellu- and synaptogyrins are tyrosine-phosphorylated proteins that serve as substrates for pp60c-src. Inspection of the cellu- and synaptogyrin sequences reveals that there is only a single cytoplasmic tyrosine in the N-terminal region but multiple conserved cytoplasmic tyrosines in the C-terminal sequence (Fig. 1, asterisks). Based on this finding, it seems likely that pp60c-src phosphorylates the cytoplasmic tail of cellu- and synaptogyrin. We confirmed this hypothesis using recombinant maltose-binding fusion proteins of the C termini of cellu- and synaptogyrin and recombinant pp60c-src, demonstrating that the cytoplasmic tails of cellu- and synaptogyrin are substrates for this tyrosine kinase (data not shown).

    DISCUSSION
Top
Abstract
Introduction
Procedures
Results
Discussion
References

Major progress has been made in recent years in the understanding of the structures and functions of synaptic vesicle proteins. Now most of the intrinsic membrane proteins of synaptic vesicles have been identified, and the roles of some of them in exocytosis have been elucidated (for review, see Ref. 1). One of the major results emerging from these studies was the realization that the mechanisms involved in the execution and regulation of synaptic vesicle fusion are not specific for synaptic vesicles. Instead, homologues to all of the proteins that were functionally characterized in synaptic vesicle exocytosis were found in other trafficking pathways where they may perform analogous functions. For example, a close homologue of synaptobrevin called cellubrevin appears to function in constitutive exocytosis similarly to synaptobrevin, and multiple forms of synaptotagmins are expressed in non-neuronal tissues (18, 20). An exception to the parallelism between synaptic vesicle proteins and proteins of constitutively active exocytic vesicles is synaptogyrin. This protein is one of the more abundant vesicle proteins that is present in all synaptic vesicles independent of neurotransmitter type but has no known nonsynaptic correlate. With cellugyrin, we have now described a protein that is closely related to synaptogyrin but primarily expressed outside of brain in tissues in which no synaptogyrin protein is detected. Cellu- and synaptogyrin are homologous to each other over their entire sequences and exhibit no major differences, suggesting similar functions. In addition, they are distantly related to synaptophysins, with which they may share an evolutionary ancestor. The co-expression of these distantly related protein families on the same synaptic vesicles and their co-evolution into synaptic vesicle-specific and ubiquitous isoforms indicates that they have evolutionarily conserved distinct functions. This conclusion is also supported by our finding that even in brain, which contains low levels of cellugyrin, cellugyrin is not present on synaptic vesicles in which synaptogyrin is abundant, indicating a different cellular site of action.

In purified synaptic vesicles, both synaptogyrin and synaptophysin I are tyrosine phosphorylated, and pp60c-src is peripherally associated with the vesicles (14-16). These intriguing observations suggest that tyrosine phosphorylation may be involved in regulating synaptic membrane traffic, a hypothesis that is supported by the finding that Ca2+ influx into neurons activates tyrosine phosphorylation (27-29). However, these observations also raise a number of questions: Does pp60c-src actually phosphorylate synaptogyrin? Is tyrosine phosphorylation a conserved feature of the cellu-/synaptogyrin protein family? Where are these proteins phosphorylated? We have addressed these questions by showing that synaptogyrin is effectively tyrosine phosphorylated by pp60c-src in transfected cells. Furthermore, we found that cellugyrin is as good a substrate for pp60c-src as synaptogyrin and that the cytoplasmic C termini of these proteins are substrates for pp60c-src. Therefore cellu- and synaptogyrins form an evolutionarily conserved protein family in vesicular membrane traffic whose members are differentially expressed but similarly tyrosine phosphorylated.

The major question now regards the function of synaptogyrin and cellugyrin. Despite extensive work on these proteins and on the synaptophysins, their distant relatives, their functions have remained elusive. Their structures and patterns of conservation suggest a role related to the vesicular membrane because a large proportion of their total sequences are devoted to transmembrane regions and their transmembrane regions are the most conserved sequences among family members. Knockout mice in synaptophysin I and in synaptogyrin are not lethal, demonstrating that these proteins are not essential for neurotransmitter release as such (30).2 These results together with the tyrosine phosphorylation of cellu-/synaptogyrins indicates that the role of synaptogyrin may be to regulate neurotransmitter release and that cellugyrin may have an analogous function in regulating membrane traffic in non-neuronal cells.

    ACKNOWLEDGEMENTS

We thank Dr. R. Jahn for the gift of synaptogyrin antibodies, Dr. B. Barylko for src antibodies, Drs. S. Butz and R. Jahn for purified synaptic vesicles, and Dr. D. Black (University of California Los Angeles) for the pp60c-src cDNA clone.

    FOOTNOTES

* This study was supported by a grant from the W. Keck Foundation and a postdoctoral fellowship from the Deutsche Forschungsgemeinschaft (to R. J.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EMBL Data Bank with accession number(s) AF039085.

Dagger To whom correspondence should be addressed. Tel.: 214-648-5022; Fax: 214-648-6426.

1 kb, kilobase(s); EST, expressed sequence tag; GST, glutathione S-transferase; bp, base pair(s).

2 R. Janz and T. C. Sudhof, unpublished observation.

    REFERENCES
Top
Abstract
Introduction
Procedures
Results
Discussion
References

  1. Südhof, T. C. (1995) Nature 375, 645-653[CrossRef][Medline] [Order article via Infotrieve]
  2. Geppert, M., Goda, Y., Hammer, R. E., Li, C., Rosahl, T. W., Stevens, C. F., Südhof, T. C. (1994) Cell 79, 717-727[Medline] [Order article via Infotrieve]
  3. Schiavo, G., Benfenati, F., Poulain, B., Rossetto, O., Polverino de Laureto, P., DasGupta, B. R., Montecucco, C. (1992) Nature 359, 832-835[CrossRef][Medline] [Order article via Infotrieve]
  4. Link, E., McMahon, H., Fischer von Mollard, G., Niemann, H., Südhof, T. C., Jahn, R. (1993) J. Biol. Chem. 268, 18423-18426[Abstract/Free Full Text]
  5. Geppert, M., Bolshakov, Y., Siegelbaum, S. A., Takei, K., De Camilli, P., Hammer, R. E., Südhof, T. C. (1994) Nature 369, 493-497[CrossRef][Medline] [Order article via Infotrieve]
  6. Geppert, M., Goda, Y., Stevens, C. F., Südhof, T. C. (1997) Nature 387, 810-814[CrossRef][Medline] [Order article via Infotrieve]
  7. Castillo, P. E., Janz, R., Südhof, T. C., Tzounopoulos, T., Malenka, R. C., Nicoll, R. A. (1997) Nature 388, 590-592[CrossRef][Medline] [Order article via Infotrieve]
  8. Rosahl, T. W., Spillane, D., Missler, M., Herz, J., Selig, D. K., Wolff, J. R., Hammer, R. E., Malenka, R. C., Südhof, T. C. (1995) Nature 375, 488-493[CrossRef][Medline] [Order article via Infotrieve]
  9. Rosahl, T. W., Geppert, M., Spillane, D., Herz, J., Hammer, R. E., Malenka, R. C., Südhof, T. C. (1993) Cell 75, 661-670[Medline] [Order article via Infotrieve]
  10. Jahn, R., Schiebler, W., Ouimet, C., and Greengard, P. (1986) Proc. Natl. Acad. Sci. U. S. A. 82, 4137-4141
  11. Johnston, P. A., Jahn, R., and Südhof, T. C. (1989) J. Biol. Chem. 264, 1268-1273[Abstract/Free Full Text]
  12. Stenius, K., Janz, R., Südhof, T. C., Jahn, R. (1995) J. Cell Biol. 131, 1801-1809[Abstract]
  13. Pang, D. T., Wang, J. K., Valtorta, F., Benfenati, F., and Greengard, P. (1988) Proc. Natl. Acad. Sci. U. S. A. 85, 762-766[Abstract]
  14. Baumert, M., Takei, K., Hartinger, J., Burger, P. M., Fischer von Mollard, G., Maycox, P. R., De Camilli, P., Jahn, R. (1990) J. Cell Biol. 110, 1285-1294[Abstract]
  15. Barnekow, A., Jahn, R., and Shartl, M. (1990) Oncogene 5, 1019-1024[Medline] [Order article via Infotrieve]
  16. Linstedt, A. D., Vetter, M. L., Bishop, J. M., Kelly, R. B. (1992) J. Cell Biol. 117, 1077-1084[Abstract]
  17. Hirano, A. A., Greengard, P., and Huganir, R. L. (1988) J. Neurochem. 50, 1447-1455[Medline] [Order article via Infotrieve]
  18. McMahon, H., Ushkaryov, Y. A., Link, E., Edelmann, L., Binz, T., Niemann, H., Jahn, R., and Südhof, T. C. (1993) Nature 364, 346-349[CrossRef][Medline] [Order article via Infotrieve]
  19. Baldini, G., Scherer, P. E., and Lodish, H. F. (1995) Proc. Natl. Acad. Sci. U. S. A. 92, 4284-4288[Abstract]
  20. Li, C., Ullrich, B., Zhang, J. Z., Anderson, R. G. W., Brose, N., Südhof, T. C. (1995) Nature 375, 594-599[CrossRef][Medline] [Order article via Infotrieve]
  21. Laube, R. E. (1994) Differentiation 56, 163-171[CrossRef][Medline] [Order article via Infotrieve]
  22. Andersson, S., Davis, D. N., Dählback, H., Jörnvall, H., and Russell, D. W. (1989) J. Biol. Chem. 264, 8222-8229[Abstract/Free Full Text]
  23. Martinez, R., Mathey-Prevot, B., Bernards, A., and Baltimore, D. (1987) Science 237, 411-415[Medline] [Order article via Infotrieve]
  24. Gorman, C. (1985) DNA Cloning, Vol. III, pp. 143-190, IRL Press, Oxford
  25. Johnston, P. A., and Südhof, T. C. (1990) J. Biol. Chem. 265, 8869-8873[Abstract/Free Full Text]
  26. Johnston, P. A., Cameron, P. L., Stukenbrok, H., Jahn, R., de Camilli, P., Südhof, T. C. (1989) EMBO J. 8, 2863-2872[Abstract]
  27. Lev, S., Moreno, H., Martinez, R., Canoll, P., Peles, E., Musacchio, J. M., Plowman, G. D., Rudy, B., Schlessinger, J. (1995) Nature 376, 737-745[CrossRef][Medline] [Order article via Infotrieve]
  28. Rusanescu, G., Qi, H., Thomas, S. M., Brugge, J. S., Halegoua, S. (1995) Neuron 15, 1415-1425[Medline] [Order article via Infotrieve]
  29. Della Rocca, G. J., Viesen, T. V., Daaka, Y., Luttrell, D. K., Luttrell, M. M., Lefkowitz, R. J. (1997) J. Biol. Chem. 272, 19125-19132[Abstract/Free Full Text]
  30. McMahon, H. T., Bolshakov, V. Y., Janz, R., Hammer, R. E., Siegelbaum, S. A., Südhof, T. C. (1996) Proc. Natl. Acad. Sci. U. S. A. 93, 4760-4764[Abstract/Free Full Text]


Copyright © 1998 by The American Society for Biochemistry and Molecular Biology, Inc.